Acadia Pharmaceuticals (ACAD - Get Report) is focused on the development and commercialization of small molecule drugs for the treatment of central nervous system disorders. This stock is trading up 9.4% to $2.38 in recent trading.
Today's Range: $2.19-$2.4052-Week Range: $0.93-$3.06 Volume: 1 million Three-Month Average Volume: 1.2 million >>5 Stocks Under $10 Set to Soar From a technical perspective, ACAD is bouncing strongly here right off its 50-day moving average of $2.21 with decent volume. This move is quickly pushing ACAD within range of triggering a near-term breakout trade. That trade will hit once ACAD manages to take out some near-term overhead resistance at $2.64 with high volume. Traders should now look for long-biased trades in ACAD as long as its trending above its 50-day, and then once it sustains a move or close above $2.64 with volume that hits near or above 1,180,710 shares. If that breakout triggers soon, then look for ACAD to setup to re-test or take out its next major overhead resistance levels at $3.06 to $3.30. Any high-volume move above $3.30 could setup ACAD to trend north of $4.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts